GenusPlus Group (GNP) is a AU-listed Industrials company in Engineering & Construction with a market capitalization of A
.7B, trading at A$9.12 on the ASX. This SniperIQ fundamentals page covers GenusPlus Group's valuation (P/E 35.1x, P/B 9.0x), profitability (net margin 4.9%), revenue (A$751M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market CapA
.7B
P/E (TTM)35.1x
Net Margin4.9%
Revenue (FY25)A$751M
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is GenusPlus Group's market cap?
GenusPlus Group (GNP) has a market capitalization of approximately A
.7B, trading at A$9.12 on the ASX. Market cap moves with the live share price.
What is GenusPlus Group's P/E ratio?
GenusPlus Group's trailing twelve-month P/E ratio is 35.1x, with a price-to-book (P/B) of 9.0x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is GenusPlus Group?
GenusPlus Group runs a net profit margin of 4.9%, a gross margin of 39.8%, and an operating margin of 7.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does GenusPlus Group generate?
GenusPlus Group reported revenue of A$751M for fiscal year 2025, with net income of A
5M and earnings per share (EPS) of 0.2. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does GenusPlus Group pay a dividend?
GenusPlus Group offers a trailing dividend yield of about 0.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is GenusPlus Group financially healthy?
GenusPlus Group carries a debt-to-equity ratio of 0.58x and a current ratio of 1.16x, with a market beta of 0.67. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is GenusPlus Group a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For GenusPlus Group (GNP) the key facts are: market cap A
.7B, P/E 35.1x, revenue A$751M, 52-week range 4.25-11.35. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track GenusPlus Group's full fundamentals live
Get GenusPlus Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.